GOSS
Gossamer Bio, Inc.
Phase 2
AI-extracted
seralutinib
pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD)
272d ago
Feb 23, 2026
SEC 8-K
verified 5mo ago
Countdown card β